세계의 입자선 치료 시장

Global Particle Therapy Market to Reach US$2.8 Billion by 2030

The global market for Particle Therapy estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Heavy Ion Therapy segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$481.4 Million While China is Forecast to Grow at 8.0% CAGR

The Particle Therapy market in the U.S. is estimated at US$481.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$432.1 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Particle Therapy Market - Key Trends & Drivers Summarized

Why Is Particle Therapy Essential in Modern Cancer Treatment?

Particle therapy has become an essential and highly effective treatment option in modern cancer care, providing precise, targeted radiation therapy with minimal damage to surrounding healthy tissue. Unlike traditional photon-based radiation, particle therapy uses charged particles like protons and carbon ions, which allow oncologists to deliver a high dose of radiation directly to tumors while sparing adjacent healthy tissues. This precision is particularly valuable in treating cancers located near critical structures, such as brain tumors, pediatric cancers, and tumors near the spinal cord, where preserving healthy tissue is crucial. As a result, particle therapy has become a cornerstone in the treatment of complex and hard-to-treat cancers, significantly improving outcomes and reducing side effects.

In addition to its accuracy, particle therapy offers a higher dose intensity at the tumor site, making it particularly effective for radioresistant tumors, which are less responsive to traditional forms of radiation. The unique properties of particle beams, such as the Bragg peak effect, allow them to release maximum energy directly at the tumor site, reducing radiation exposure beyond the tumor. This advantage minimizes side effects and long-term complications, which is especially beneficial for pediatric patients and those with cancers near sensitive organs. For patients, particle therapy means a potentially shorter treatment course with fewer complications, making it a preferred option in modern oncology for high-precision cancer care.

Moreover, particle therapy aligns with the growing trend of personalized cancer treatment, as it allows for treatment plans that are tailored to the unique characteristics of each patient’s tumor. With advancements in imaging and treatment planning, oncologists can use particle therapy to target tumors with unparalleled precision based on size, shape, and location, providing an individualized approach that improves treatment efficacy. This capability makes particle therapy an essential part of precision oncology, addressing the need for highly targeted treatments that enhance patient outcomes while reducing the physical and emotional burden of cancer treatment.

How Are Technological Advancements Enhancing Particle Therapy?

Technological advancements are significantly enhancing the effectiveness, accessibility, and efficiency of particle therapy, broadening its application and appeal in cancer treatment. One of the most significant innovations in this field is the development of intensity-modulated proton therapy (IMPT), which allows for even greater precision in dose distribution. IMPT enables oncologists to modulate the intensity of the proton beam, shaping it more accurately to match the tumor’s contours and sparing nearby healthy tissues even more effectively. This enhanced control reduces the risk of radiation-induced side effects and is particularly beneficial for complex, irregularly shaped tumors. As IMPT technology continues to advance, it offers improved outcomes for patients with challenging cancer types, increasing the overall effectiveness of particle therapy.

The integration of advanced imaging technologies, such as real-time MRI and PET scans, has further improved the accuracy of particle therapy by providing detailed, real-time images that guide treatment. These imaging technologies enable oncologists to precisely locate tumors and adjust treatment parameters to account for tumor movement, such as breathing or patient shifts, which is particularly important for tumors in the lungs or abdomen. By combining real-time imaging with particle therapy, oncologists can deliver more accurate and adaptive treatments, ensuring that radiation is consistently targeted to the tumor while sparing surrounding tissues. This innovation supports adaptive particle therapy, allowing treatment to be dynamically adjusted as the tumor changes in response to therapy, enhancing effectiveness and minimizing side effects.

The development of compact and cost-effective particle therapy systems, such as single-room proton therapy units, has increased the accessibility and affordability of particle therapy. Traditionally, particle therapy required large, complex, and expensive facilities, limiting its availability to a select number of centers worldwide. However, advancements in compact systems have made it possible for more hospitals and cancer centers to adopt particle therapy technology, making it accessible to a broader patient population. These compact systems reduce the need for large-scale infrastructure, significantly lowering costs and enabling community hospitals and regional cancer centers to offer this advanced treatment. By making particle therapy more affordable and widely available, these technological advancements are expanding its reach, providing more patients with access to high-precision cancer care.

What Are the Benefits of Particle Therapy for Patients and Healthcare Systems?

Particle therapy offers substantial benefits for both patients and healthcare systems, providing a precise, effective, and patient-friendly approach to cancer treatment. For patients, one of the primary advantages of particle therapy is its ability to minimize damage to healthy tissues, reducing both short-term and long-term side effects. This tissue-sparing property is particularly valuable for pediatric patients and those with tumors near sensitive structures, as it reduces the risk of complications and preserves quality of life. By minimizing radiation exposure to surrounding tissues, particle therapy allows patients to undergo treatment with fewer side effects, leading to a quicker recovery and enabling a better post-treatment quality of life. This advantage is especially beneficial for young patients, as it lowers the risk of secondary cancers and developmental issues associated with radiation exposure.

For healthcare systems, particle therapy reduces the long-term care costs associated with managing radiation-induced side effects and complications. Traditional radiation treatments often require extensive post-treatment care to manage side effects such as radiation dermatitis, damage to organs, and even secondary malignancies. With particle therapy’s precise targeting, the incidence of such complications is significantly reduced, leading to fewer hospital admissions and a lower demand for follow-up treatments. This reduction in post-treatment complications translates into cost savings for healthcare systems and allows resources to be allocated more effectively. By supporting better patient outcomes with fewer long-term effects, particle therapy contributes to a more sustainable approach to cancer care, which benefits healthcare systems financially and operationally.

Particle therapy also aligns well with the shift toward personalized and precision oncology, enabling healthcare providers to deliver treatments that are tailored to the unique characteristics of each patient’s tumor. With advanced imaging and treatment planning technologies, oncologists can develop individualized particle therapy protocols based on tumor location, size, and shape. This personalization enhances treatment efficacy and optimizes resource use, as patients receive precisely the amount of radiation needed without unnecessary exposure. For healthcare systems, the ability to provide tailored treatment improves patient satisfaction and outcomes, reinforcing the value of particle therapy as part of a comprehensive cancer care program. Together, these benefits—improved quality of life, reduced long-term costs, and support for precision oncology—highlight the transformative potential of particle therapy for patients and healthcare providers alike.

What Is Fueling the Growth in the Particle Therapy Market?

The growth in the particle therapy market is driven by factors such as the rising incidence of cancer, increasing demand for minimally invasive and precise cancer treatments, advancements in particle therapy technology, and expanded access to proton and carbon ion therapy centers. As cancer incidence continues to rise globally, there is an urgent demand for advanced treatment options that improve outcomes while minimizing side effects. Particle therapy, with its precise targeting and reduced impact on healthy tissues, meets this demand by providing an effective, patient-friendly alternative to traditional radiation. This demand is particularly strong in pediatric oncology, where the need for tissue-sparing therapies is paramount. As the global cancer burden grows, the demand for high-precision treatments like particle therapy is expected to drive market expansion.

The increasing demand for minimally invasive cancer treatments has further fueled growth in the particle therapy market. Patients and healthcare providers alike are seeking treatments that provide effective results with fewer side effects and shorter recovery times. Particle therapy, with its ability to deliver high-dose radiation directly to tumors while sparing surrounding tissues, aligns with this demand for precision and minimal invasiveness. The market is benefiting from a growing awareness among patients and providers about the advantages of particle therapy over traditional radiation, leading to higher adoption rates. As patients increasingly seek treatments that balance efficacy with quality of life, particle therapy is emerging as a preferred option for complex and high-risk cancers.

Advancements in particle therapy technology, such as compact and single-room systems, are also driving market growth by making particle therapy more accessible and affordable. These compact systems reduce the infrastructure and cost requirements of traditional particle therapy facilities, enabling more hospitals and cancer centers to adopt this advanced technology. Additionally, innovations like intensity-modulated proton therapy and adaptive treatment planning have enhanced the precision and adaptability of particle therapy, increasing its effectiveness across a broader range of cancer types. As technology continues to improve, particle therapy is becoming more viable for a wider range of healthcare facilities, expanding patient access and fueling market growth.

The expansion of particle therapy centers, particularly in regions like North America, Europe, and Asia-Pacific, is another significant factor in market growth. Governments and healthcare organizations are investing in particle therapy infrastructure, recognizing its benefits for cancer care and the potential for long-term healthcare cost savings. Many countries are also offering reimbursement and funding support to make particle therapy more accessible to patients. As more particle therapy centers are established globally, the availability and awareness of this treatment are increasing, driving further demand. Together, these factors—rising cancer incidence, demand for precise treatments, technological advancements, and infrastructure expansion—are driving robust growth in the particle therapy market, positioning it as a crucial component of modern oncology and personalized cancer care.

SCOPE OF STUDY:

The report analyzes the Particle Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Proton Therapy, Heavy Ion Therapy); System (Multi-Room Systems, Single-Room Systems); Application (Treatment, Research)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 22 Featured) -

• Accuray Incorporated
• Advanced Oncotherapy
• Brainlab
• Danfysik A/S
• Elekta AB
• Hitachi Ltd.
• IBA Worldwide
• Koninklijke Philips N.V.
• Mevion Medical Systems
• Mitsubishi Electric Corporation
• Optivus Proton Therapy Inc.
• Panacea
• ProTom International
• Provision Healthcare
• PTW Freiburg GmbH
• SAH Global LLC
• Shinva Medical Instrument Co. Ltd
• Sumitomo Heavy Industries Ltd.
• Varian Medical Systems Inc.
• xstrahl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Particle Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Cancer Drives Demand for Particle Therapy Solutions
  • Advancements in Proton Therapy Technologies Propel Particle Therapy Market
  • Increasing Adoption of Carbon Ion Therapy Expands Addressable Market
  • Growing Focus on Minimally Invasive Cancer Treatments Sets the Stage for Market Expansion
  • Innovations in Beam Delivery Systems Propel Particle Therapy Adoption
  • Demand for Pediatric Cancer Treatments Expands Particle Therapy Applications
  • Growing Awareness About Particle Therapy in Developing Economies Bodes Well for Market Growth
  • Increasing Use in Recurrent Tumor Treatments Sets the Stage for Market Growth
  • Demand for Proton Beam Therapy in Brain and Lung Cancers Spurs Adoption
  • Increasing Use in Proton Therapy for Prostate Cancer Sets the Stage for Market Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Particle Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Particle Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Particle Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Heavy Ion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Heavy Ion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Heavy Ion Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Multi-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Multi-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Multi-Room Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Single-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Single-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Single-Room Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 22: World Particle Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: USA 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: USA 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: Canada 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: Canada 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• JAPAN
  • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Japan 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Japan 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• CHINA
  • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 50: China Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: China 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 53: China Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: China 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• EUROPE
  • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Particle Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Particle Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Europe 15-Year Perspective for Particle Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Europe 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• FRANCE
  • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 71: France Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: France Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: France 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 74: France Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: France 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• GERMANY
  • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 80: Germany Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Germany Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Germany 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 89: Italy Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Italy Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Italy 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Italy 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 98: UK Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: UK Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: UK 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 101: UK Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: UK 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Rest of Europe Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Rest of Europe 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Rest of Europe Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Rest of Europe 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Rest of Europe Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Rest of Europe 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Asia-Pacific Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Asia-Pacific 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Asia-Pacific Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Asia-Pacific 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Asia-Pacific Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Asia-Pacific 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
• REST OF WORLD
  • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Rest of World Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Rest of World 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
  • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of World Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Rest of World 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
  • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of World Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of World 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030

IV. COMPETITION